SINGULAR GENOMICS SYSTEMS
(NASDAQ: OMIC)
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
13.320
+0.320
(+2.46%)
Range
12.550 - 14.370
(14.50%)
Open
12.550
Previous Close
13.000
Bid Price
1.010
Bid Volume
10
Ask Price
-
Ask Volume
22
Volume
57,274
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis